Nestle Health Science US Holdings Inc. 13D and 13G filings for Prometheus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 10:20 am Purchase |
2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Nestle Health Science US Holdings Inc. | 3,730,841 9.580% |
3,730,841 (New Position) |
Filing |